Companies

Tonix Pharmaceuticals Holding Corp. (TNXP) SEC filings

CIK 0001430306 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in NV · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)13.1 M7.8 M
Net income (USD)-124.0 M-116.7 M-110.2 M
Diluted EPS (USD/shares)-14.57-14720.25-20.01

Latest filings

FiledFormDescriptionPeriod
2026-10-158-K8-K items 2.02,8.012026-10-15
2026-10-028-K8-K items 8.012026-10-01
2026-09-228-K8-K items 8.01,9.012026-09-22
2026-09-088-K8-K items 8.01,9.012026-09-08
2026-09-08332026-09-04
2026-08-31442026-08-27
2026-08-244STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES2026-08-20
2026-08-188-K8-K items 5.02,8.012026-08-18
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13GSCHEDULE 13G
2026-08-1010-QQUARTERLY REPORT2026-06-30
2026-08-108-K8-K items 2.02,9.012026-08-10
2026-08-038-K8-K items 7.01,8.01,9.012026-08-03
2026-07-218-K8-K items 5.022026-07-20
2026-07-138-K8-K items 7.01,8.01,9.012026-07-13
2026-07-09442026-06-30
2026-07-01S-8S-8
2026-06-298-K8-K items 7.01,8.01,9.012026-06-29
2026-06-15SCHEDULE 13GSCHEDULE 13G
2026-06-15442026-06-12
2026-06-09442026-06-08
2026-06-09442026-06-09
2026-06-088-K8-K items 7.01,8.01,9.012026-06-08
2026-05-278-K8-K items 7.01,8.01,9.012026-05-27
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 8-K 517, 4 179, 424B5 32, 10-Q 29, SC 13G/A 25, CORRESP 24, DEF 14A 19, SC 13G 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TNXP (0.002 USD), /gw/filings/filings?ticker=TNXP&form=8-K, /gw/filings/facts?ticker=TNXP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange